Immtech Pharmaceuticals aims...

to have a significant positive impact on global health. We plan to achieve this by developing new drug candidates to treat infectious diseases and through the sales and distribution of approved drugs. We are focused on providing healthcare solutions to the global community.

  • The infectious diseases market represents an estimated US$46 billion in annual sales.
  • Immtech has exclusive license to a family of compounds covered by patents issued worldwide. Our development efforts have been supported by funding from the National Institutes of Health and the Bill and Melinda Gates Foundation through grants to our Scientific Consortium, led by the University of North Carolina in Chapel Hill(UNC)
  • Our global focus includes extensive experience and established business relationships in China, a rapidly expanding market for healthcare products and services.

Company Information

Learn about Immtech Pharmaceuticals:

Company Overview our history, proprietary technology platform, products and prospects
Executive Team
Board of Directors
Corporate Governance
Career Opportunities
Company FAQs

Investor Center

Learn about investing in Immtech Pharmaceuticals:

Opportunities our business model and proprietary technology platform
Technology mechanisms of action, Scientific Consortium and publications
SEC Filings
Investor FAQs

Press Room

go to Press Releases



Terms of Use | Privacy Policy
© 2008 Immtech. All Rights Reserved